4/21/2025 | Scotiabank
5 of 5 stars | Nat Schindler Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Sector Outperform ➝ Sector Outperform | $306.00 ➝ $250.00 | +50.88% | |
4/21/2025 | Raymond James
4 of 5 stars | Josh Beck Subscribe to MarketBeat All Access for the recommendation accuracy rating | Reiterated Rating | Strong-Buy ➝ Outperform | $275.00 ➝ $195.00 | +13.04% | |
4/16/2025 | Cantor Fitzgerald
3 of 5 stars | Deepak Mathivanan Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Overweight ➝ Overweight | $270.00 ➝ $230.00 | +30.79% | |
4/14/2025 | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | Gil Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Buy ➝ Buy | $280.00 ➝ $230.00 | +26.50% | |
4/14/2025 | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | Ronald Josey Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Buy ➝ Buy | $273.00 ➝ $225.00 | +21.71% | |
4/14/2025 | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Lower Target | Buy | $287.00 ➝ $206.00 | +11.43% | |
4/14/2025 | Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Lower Target | Outperform | $285.00 ➝ $240.00 | +29.82% | |
4/14/2025 | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | Brian Nowak Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Overweight ➝ Overweight | $280.00 ➝ $245.00 | +32.53% | |
4/14/2025 | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | Nicholas Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Market Outperform ➝ Market Outperform | $285.00 ➝ $240.00 | +29.82% | |
4/10/2025 | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | Youssef Squali Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Buy ➝ Buy | $265.00 ➝ $230.00 | +20.36% | |
Get the Latest News and Ratings for AMZN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amazon.com and its competitors with MarketBeat's FREE daily newsletter.
|
4/9/2025 | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | Justin Post Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Buy ➝ Buy | $257.00 ➝ $225.00 | +31.84% | |
4/9/2025 | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | James Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Outperform ➝ Outperform | $285.00 ➝ $255.00 | +49.42% | |
4/8/2025 | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | Doug Anmuth Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Overweight ➝ Overweight | $270.00 ➝ $220.00 | +23.45% | |
4/1/2025 | Westpark Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | Curtis Shauger Subscribe to MarketBeat All Access for the recommendation accuracy rating | Initiated Coverage | Buy | $280.00 | +47.17% | |
3/31/2025 | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | Brent Thill Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Buy ➝ Buy | $275.00 ➝ $250.00 | +29.72% | |
2/25/2025 | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating | Lower Target | Equal Weight ➝ Equal Weight | $207.00 ➝ $203.00 | -3.23% | |
2/13/2025 | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Reiterated Rating | Buy ➝ Buy | | | |
2/12/2025 | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | Rob Sanderson Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Buy ➝ Buy | $275.00 ➝ $285.00 | +23.46% | |
2/10/2025 | Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | H. Wang Subscribe to MarketBeat All Access for the recommendation accuracy rating | Downgrade | Strong-Buy ➝ Moderate Buy | | | |
2/7/2025 | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | Tom Forte Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Buy ➝ Buy | $260.00 ➝ $280.00 | +22.19% | |
2/7/2025 | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | Ross Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Overweight ➝ Overweight | $235.00 ➝ $265.00 | +15.64% | |
2/7/2025 | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | Brad Erickson Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Outperform ➝ Outperform | $255.00 ➝ $265.00 | +15.71% | |
2/7/2025 | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | Jason Helfstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Outperform ➝ Outperform | $230.00 ➝ $260.00 | +13.00% | |
2/7/2025 | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | Mark Kelley Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Buy ➝ Buy | $245.00 ➝ $275.00 | +19.54% | |
2/7/2025 | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | Scott Devitt Subscribe to MarketBeat All Access for the recommendation accuracy rating | Reiterated Rating | Outperform ➝ Outperform | $280.00 ➝ $280.00 | +21.74% | |
2/7/2025 | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | Thomas Champion Subscribe to MarketBeat All Access for the recommendation accuracy rating | Reiterated Rating | Overweight ➝ Overweight | $225.00 ➝ $265.00 | +13.74% | |
2/7/2025 | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | Eric Sheridan Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Buy ➝ Buy | $240.00 ➝ $255.00 | +6.77% | |
2/7/2025 | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | Joseph Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | Reiterated Rating | Outperform ➝ Outperform | $275.00 ➝ $275.00 | +15.14% | |
2/7/2025 | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | Laura Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating | Reiterated Rating | Buy ➝ Buy | $250.00 ➝ $250.00 | +4.68% | |
2/7/2025 | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | Barton Crockett Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Buy ➝ Buy | $236.00 ➝ $287.00 | +20.17% | |
2/4/2025 | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | Daniel Kurnos Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Buy ➝ Buy | $215.00 ➝ $265.00 | +10.65% | |
1/13/2025 | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | Christopher Johnen Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Buy ➝ Buy | $225.00 ➝ $270.00 | +24.21% | |
1/3/2025 | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Khajuria Subscribe to MarketBeat All Access for the recommendation accuracy rating | Boost Target | Outperform ➝ Outperform | $250.00 ➝ $270.00 | +22.60% | |
12/20/2024 | Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy ➝ Buy | $245.00 ➝ $290.00 | +31.21% | |
12/18/2024 | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Outperform ➝ Outperform | $235.00 ➝ $265.00 | +15.12% | |
12/16/2024 | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy | $230.00 ➝ $264.00 | +15.00% | |
12/13/2024 | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Outperform ➝ Outperform | $220.00 ➝ $260.00 | +13.55% | |
12/12/2024 | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy ➝ Buy | $240.00 ➝ $265.00 | +15.18% | |
12/9/2024 | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy ➝ Buy | $220.00 ➝ $250.00 | +10.12% | |
12/3/2024 | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Reiterated Rating | Outperform ➝ Outperform | $236.00 ➝ $236.00 | +12.00% | |
Warning: “DOGE Collapse” imminent (Ad) Elon Strikes Back
You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead. Click here to see what they’re predicting now. |
11/26/2024 | Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy ➝ Buy | $235.00 ➝ $248.00 | +23.11% | |
11/26/2024 | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy ➝ Buy | $225.00 ➝ $235.00 | +16.65% | |
11/1/2024 | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Positive ➝ Positive | $220.00 ➝ $230.00 | +15.35% | |
11/1/2024 | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy | $225.00 ➝ $245.00 | +31.44% | |
11/1/2024 | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Outperform ➝ Outperform | $240.00 ➝ $260.00 | +39.48% | |
10/11/2024 | Pivotal Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wlodarczak Subscribe to MarketBeat All Access for the recommendation accuracy rating | Initiated Coverage | Buy | $260.00 | +39.30% | |
8/2/2024 | Itau BBA Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Downgrade | Outperform ➝ Market Perform | $186.00 | +1.05% | |
7/10/2024 | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | | $225.00 ➝ $245.00 | +22.91% | |
5/2/2024 | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy ➝ Buy | $185.00 ➝ $205.00 | +12.76% | |
8/11/2023 | Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Buy ➝ Buy | $220.00 ➝ $230.00 | +65.99% | |
8/4/2023 | Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Outperform | $176.00 ➝ $189.00 | +32.89% | |
8/4/2023 | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Upgrade | Underperform ➝ Neutral | $140.00 | -0.60% | |
7/9/2023 | CICC Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Initiated Coverage | Outperform | | | |
6/7/2023 | Piper Sandler Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating | | Boost Target | Overweight | $130.00 ➝ $150.00 | +18.47% | |